Argent Biopharma Financial Overview
Argent Biopharma's market cap is currently $3.92M. The company's EPS TTM is $-0.051666000000000004; its P/E ratio is -0.26; Argent Biopharma is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
